DiscoverFlot.bio x Philip HemmeDragan Grabulovski, Araris ๐Ÿ‡จ๐Ÿ‡ญ | ADC Linkers, Replacing Chemotherapy | E41
Dragan Grabulovski, Araris ๐Ÿ‡จ๐Ÿ‡ญ | ADC Linkers, Replacing Chemotherapy | E41

Dragan Grabulovski, Araris ๐Ÿ‡จ๐Ÿ‡ญ | ADC Linkers, Replacing Chemotherapy | E41

Update: 2025-10-08
Share

Description

Philip meets up with Dragan Grabulovski, CEO of the startup Araris, at Lake Zurich to chat about the companyโ€™s work with antibody-drug conjugates (ADCs).They talk about Ararisโ€™ huge $400M upfront buyout by Taiho Pharma of Japan, Draganโ€™s extensive history as a biotech entrepreneur, and Ararisโ€™ vision to replace chemotherapy with ADCs.โญ๏ธ ABOUT THE SPEAKERDragan Grabulovski is a co-founder of the startup Araris and became CEO in 2023. He previously worked as a biotech consultant and startup coach in Switzerland. He co-founded the biotech company Covagen in 2007, which was acquired by Johnson & Johnson in 2014. Dragan has a Masterโ€™s degree and a PhD in Pharmaceutical Sciences from ETH Zurich.๐Ÿ”—ย LINKS MENTIONED- Ararisโ€™ website: https://www.ararisbiotech.com/- Taiho Pharma acquires Araris: https://www.ararisbiotech.com/docs/250316_250317-araris-taiho-pr.pdf- Robin Carr, Myricx Bio ๐Ÿ‡ฌ๐Ÿ‡ง | New ADC Payloads, London Biotech Startups | E38: https://flot.bio/episode/robin-carr-myricx-bio-adc/- Dominik Schumacher, Tubulis ๐Ÿ‡ฉ๐Ÿ‡ช | Founder-led ADC Biotech โญ๏ธ | E19: https://flot.bio/episode/dominik-schumacher-tubulis/- ETH entrepreneurship and terms: https://ethz.ch/staffnet/en/news-and-events/internal-news/archive/2025/07/new-business-creation-regulations-and-equity-and-licensing-policy.html ๐Ÿ“œ TRANSCRIPTRead the full transcript here: https://flot.bio/episode/dragan-grabulovski-araris-adc/๐Ÿ’ธย DONATEWe welcome donations from individuals and businesses to support our podcast and allow us to create even more content: https://www.paypal.me/PhilipHemmeโญ๏ธ SPONSORSHIPReady to amplify your brand to influential leaders in biotech and biopharma? Contact nick@flot.bio and unlock sponsorship opportunities in our podcasts!๐Ÿซถ FOLLOW US- Newsletter: http://eepurl.com/h_fnmH- LinkedIn: https://www.linkedin.com/company/flot-bio/- X (Twitter): https://x.com/FlotBio๐Ÿ™ LIKE/FOLLOW/REVIEWDid you enjoy the episode? Please hit the like and subscribe button. Also, please let me know your thoughts in the comments below.๐ŸŽ™๏ธ ABOUT FLOT.BIOFlot.bio is a show to watch the best Europeans in biotech to help you grow. Hosted by Philip Hemme. 25k monthly views. Free.โฐ TIMESTAMPS- [00:00:00 ] Intro- [00:02:08 ] Ararisโ€™ acquisition by Taiho Pharma- [00:08:29 ] Covagen: Dragan Grabulovskiโ€™s first exit- [00:12:54 ] The origins of Araris and its ADC tech- [00:22:14 ] How to value a technology platform - [00:29:34 ] The burgeoning ADC market- [00:41:53 ] ADCs replacing chemotherapy- [00:46:15 ] The Swiss biotech ecosystem- [01:00:53 ] Quickfire questions

Commentsย 
In Channel
loading
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Dragan Grabulovski, Araris ๐Ÿ‡จ๐Ÿ‡ญ | ADC Linkers, Replacing Chemotherapy | E41

Dragan Grabulovski, Araris ๐Ÿ‡จ๐Ÿ‡ญ | ADC Linkers, Replacing Chemotherapy | E41

Flot.bio